Logo Prima Biomed


Welcome to the Newsroom

02 May 2016

Japanese Patent grants for IMP321 in Cancer


ENGLISH

SYDNEY, AUSTRALIA - Prima BioMed Ltd (ASX: PRR; NASDAQ: PBMD) (“Prima”, the “Company”) announces the granting of patent number5908210 entitled “Use of Recombinant LAG-3 or the Derivatives thereof for Eliciting Monocyte Immune Response” by the Japanese Patent Office.

(...)